Kodoy

Kodoy is an India-based social venture focused on affordable technologies for Active Longevity. Kodoy is catalysing the development of relevant frontier technologies such as computer vision, gene editing, biopharmaceuticals, natural proteomic extracts, stem cell and mRNA, which have the potential to arrest biological ageing, thus extending the average lifespan to 120+ healthy years. Kodoy is currently working on cost optimisation of existing technologies such as cellular level digital twins, wide spectrum prophylactics, precision diagnostics, cutting-edge therapeutics, personalised nutraceuticals and artificial intelligence. The Kodoy platform helps one access, upload and analyse his genomic and other health data, to identify and evaluate available options to enhance longevity. The goal is to help prevent infectious diseases, reverse lifestyle diseases and enhance active lifespan, without degradation of mobility, memory or metabolic functioning. Kodoy established in 2014 has since been pursuing the goal of mitigating the harmful effects of environmental degradation, digital society and compromised food chain; by studying the pathways through which pollution, nutrition deficiencies and digital network affect our health and longevity. Kodoy is not a replacement or substitute for a doctor, hospital or other healthcare services. Instead, it is a structured data platform built on artificial intelligence, deep learning and neural networks for the compilation and comparison of longitudinal health data to identify patterns for timely intervention - to predict and prevent illness. The Kodoy open source stack initially targets the top 5% and 25% of the population of the developing and developed countries, respectively. Kodoy data platform is a smartphone-accessed SaaS solution priced at INR 15,000 per user per annum. The 250 GB user database can be stored like an app on the smartphone's home screen, without using the phone's memory or the App stores.